Stay updated on Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added revision: v3.4.2 and removed the funding lapse and government operating status notices (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding affecting data currency has been added, and the page now shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T07:55:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and made minor metadata label changes (capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), with the revision header updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:49:43.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:47.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new footer Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T12:30:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.